...between nucleosome turnover and PRE function, while achieving significant technological innovation. The outgoing phase will be hosted by Dr. Kami Ahmad at Harvard Medical School, in Boston, while Dr. Geneviève Almouzni at the Curie Institute, in Paris will be the return host."